<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ivax corp. and marketing Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ivax+corp.+and+marketing.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to ivax corp. and marketing]]></description>
	<s:counts start="0" returned="5" found="5" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200707/ai_n19769415]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 July 2007-Research and Markets: Teva is The Clear  Market Leader Since Its 2006 Purchase of IVAX States New Report  Opportunities and Challenges for Generic Drugs In The UK  2007C1994-2007 M2 COMMUNICATIONS LTD    RDATE:04072007    Dublin - Research and Markets ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/clear.html"><![CDATA[Clear]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[leader]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/u.k..html"><![CDATA[U.K.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX to Begin Marketing Gabapentin Capsules in March, Tablets in April, Prior to End of Alpharma's Exclusivity Periods]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Feb_11/ai_n9511611]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation Announces Settlement of Litigation Against FDA and Alpharma]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 11 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Names Vice President of Sales and Marketing]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_April_25/ai_85057255]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 25 Apr 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Corporation Receives Final Approval for European Marketing of PAXENE; European Commission Adopts Decision on Marketing Authorization]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_July_21/ai_55217693]]></link>
		<description><![CDATA[MIAMI--BUSINESS WIRE--July 21, 1999--]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Jul 1999 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/european+commission.html"><![CDATA[European Commission]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Ivax, Knoll End Their Joint Venture, Enter Marketing, Royalty Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199701/ai_n13234704]]></link>
		<description><![CDATA[MIAMI-BASED IVAX Corporation and the Knoll AG unit of BASF have ended  their drug distribution joint venture in Europe in favor of an agreement  granting marketing rights to Knoll and providing royalties to Ivax.     A March 1995 agreement gave each a 5  MIAMI-BASED...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 27 Jan 1997 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/basf+ag.html"><![CDATA[BASF AG]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BASF Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">BASF Y,IVX</category>
	</item>
</channel>
</rss>
